As of June 30, 2026, YCCHEM CO. LTD. carries a market capitalization of 221.42B, placing it among publicly traded companies globally. Its enterprise value stands at 276.36B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 221.42B |
| Enterprise Value | 276.36B |
YCCHEM CO. LTD.'s next confirmed earnings release is scheduled for November 13, 2026.
| Earnings Date | 11/13/2026 |
As of June 30, 2026, YCCHEM CO. LTD. has 20.22M shares outstanding.
| Shares Outstanding | 20.22M |
As of June 30, 2026, YCCHEM CO. LTD. trades at a trailing price-to-earnings ratio of 68.99. The price-to-sales ratio is 2.25, and the price-to-book ratio stands at 4.50.
| PE Ratio | 68.99 |
| PS Ratio | 2.25 |
| PB Ratio | 4.50 |
| P/TBV Ratio | 5.69 |
| P/FCF Ratio | -14.19 |
| P/OCF Ratio | 122.99 |
As of June 30, 2026, YCCHEM CO. LTD. trades at an EV/EBITDA multiple of 26.94 - the valuation measure that neutralizes differences in capital structure, tax rates, and depreciation policy, making it the standard yardstick for comparing companies across an industry. The EV/Sales ratio of 2.81 reflects the premium investors pay for the company's revenue stream, a useful check when earnings are depressed or negative. Its EV/EBIT multiple of 64.12 values the business against core operating earnings after depreciation, a stricter test than EV/EBITDA for capital-intensive businesses. These enterprise value multiples are built on an enterprise value of 276.36B versus a market cap of 221.42B, with the gap driven by net debt and cash on the balance sheet.
| EV / Sales | 2.81 |
| EV / EBITDA | 26.94 |
| EV / EBIT | 64.12 |
As of June 30, 2026, YCCHEM CO. LTD. maintains a current ratio of 0.70, meaning it holds 0.7x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 165.07, indicating elevated leverage, while an interest coverage ratio of 2.31 demonstrates limited ability to service its debt obligations.
| Current Ratio | 0.70 |
| Quick Ratio | 0.29 |
| Debt / Equity | 165.07 |
| Debt / EBITDA | 7.92 |
| Interest Coverage | 2.31 |
Over the twelve months ended June 30, 2026, YCCHEM CO. LTD. posted a return on equity (ROE) of 6.74, showing how much profit the company earns on every dollar of shareholder capital. Return on assets (ROA) stands at 2.14, measuring how efficiently the asset base is converted into earnings. The company generates approximately 538.73M in revenue per employee across its workforce of 182.50, a quick read on workforce productivity versus industry peers. Inventory turnover of 5.34 indicates how many times YCCHEM CO. LTD. sells and replaces its inventory over a year, a key working capital efficiency ratio.
| Return on Equity (ROE) | 6.74 |
| Return on Assets (ROA) | 2.14 |
| Revenue Per Employee | 538.73M |
| Employee Count | 182.50 |
| Inventory Turnover | 5.34 |
Over the twelve months ended June 30, 2026, YCCHEM CO. LTD. recorded an income tax benefit of -680.97M rather than an expense, typically from losses, carryforwards, or the release of a tax provision. Taxes are levied on pretax income of 2.53B, leaving 3.21B in net income after tax - the gap is what shifts in the tax rate do to reported earnings and EPS.
| Income Tax | -680.97M |
As of the close on October 23, 2026, YCCHEM CO. LTD.'s stock has declined approximately 17.27% over the past 52 weeks. The 50-day moving average sits at 10,481.80, while the 200-day moving average is 11,469.98.
| 52-Week Price Change | -17.27% |
| 50-Day Moving Average | 10,481.80 |
| 200-Day Moving Average | 11,469.98 |
Over the twelve months ended June 30, 2026, YCCHEM CO. LTD. generated 98.32B in revenue and converted that into 3.21B in net income, yielding earnings per share of 155.27. EBITDA reached 10.26B, while operating income came in at 4.31B.
| Revenue | 98.32B |
| Gross Profit | 25.92B |
| Operating Income | 4.31B |
| Pretax Income | 2.53B |
| Net Income | 3.21B |
| EBITDA | 10.26B |
| EBIT | 4.31B |
| Earnings Per Share (EPS) | 155.27 |
As of June 30, 2026, YCCHEM CO. LTD. holds 26.31B in cash and equivalents against 81.25B in total debt, resulting in a net debt position of 77.76B. Total book value stands at 49.23B, with working capital of -27.65B providing operational flexibility.
| Cash & Cash Equivalents | 26.31B |
| Total Debt | 81.25B |
| Net Debt | 77.76B |
| Equity (Book Value) | 49.23B |
| Book Value Per Share | 2,434.34 |
| Working Capital | -27.65B |
YCCHEM CO. LTD. produced 1.80B in operating cash flow over the twelve months ended June 30, 2026. After subtracting -17.75B in capital expenditures, free cash flow totaled -15.95B - equivalent to -788.91 per share.
| Operating Cash Flow | 1.80B |
| Capital Expenditures | -17.75B |
| Free Cash Flow | -15.95B |
| FCF Per Share | -788.91 |
Over the twelve months ended June 30, 2026, YCCHEM CO. LTD. posted a gross margin of 26.36, reflecting its pricing power and cost economics. The operating margin of 4.38 and net profit margin of 3.26 provide insight into operational efficiency.
| Gross Margin | 26.36 |
| Operating Margin | 4.38 |
| Pretax Margin | 2.57 |
| Profit Margin | 3.26 |
| EBITDA Margin | 10.43 |
These figures cover the twelve months ended June 30, 2026. Free cash flow yield is negative at -7.05: the business is consuming cash rather than generating it, so any dividend is not covered by free cash flow. Total shareholder yield is negative at -8.62, meaning YCCHEM CO. LTD. raised more capital through share issuance and new debt than it returned via dividends and buybacks.
| Shareholder Yield | -8.62 |
| FCF Yield | -7.05 |
YCCHEM CO. LTD.'s most recent stock split took place on April 29, 2026 with a 1:2 split ratio.
| Last Split Date | 4/29/2026 |
| Split Ratio | 1:2 |
As of June 30, 2026, YCCHEM CO. LTD. has an Altman Z-Score of 1.63, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | 1.63 |
Already premium?